<< Back to News

System Formulary Update
Polatuzumab vedotin SDV
January 27, 2025

Situation: Polatuzumab vedotin (Polivy) 30 mg SDV for injection was approved for addition to the UNC Health System Formulary at the System Pharmacy and Therapeutics Committee meeting.

Background: The following medications were reviewed:

• Polatuzumab vedotin (Polivy) 30 mg SDV for injection

Assessment/Recommendation: System P&T voted to include the following products on the UNC Health Medication Formulary with restriction to outpatient/clinic encounters only (i.e., no inpatient use)

• Polatuzumab vedotin (Polivy) 30 mg IV Solution

Note: Stock of this formulary product may vary at individual entities 

Formulary/Epic Changes will Go-Live on Tuesday, March 4^th